Another Appetite-suppressing Hormone Found
Joining leptin, melanocortin, and ghrelinin the group of appetite-suppressinghormones is obestatin, which is producedby the same gene that producesghrelin. Researchers, led by AaronHsueh, PhD, of Stanford University, useddata gathered by the Human GenomeProject in their discovery. Dr. Hsuehfound that treating rats with obestatinsuppressed their food intake—whichopens possibilities to develop the drugfor humans, either by injection or possiblya nasal spray. Scientists caution,however, that the effects of obestatinmay be limited and may cause an illnessor nausea that decreases appetite. Todate, research on appetite-suppressinghormones has yet to produce a cure forobesity.
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025